TCMD DEADLINE TOMORROW: Hagens Berman, Nationwide Trial Attorneys, Alerts Tactile Methods Expertise (TCMD) Buyers to Utility Deadline, Buyers with Losses Ought to Contact the Agency | 2020-11-29 | Press Releases

0
8
NNOX DEADLINE TOMORROW: Hagens Berman, National Trial Attorneys, Encourages Nano-X Imaging (NNOX) Investors Who Suffered Losses to Contact Its Attorneys, Investor Fraud Application Deadline Tomorrow | 2020-11-15 | Press Releases

San Francisco, Calif .– (Newsfile Corp. – November 29, 2020) – Hagens Berman urges Tactile Systems Technology (NASDAQ: TCMD) investors to file their losses now. The company has filed a class action lawsuit for securities fraud and certain investors may face sufficient losses to move on behalf of the lead plaintiff.

Classes: May 7, 2018 – June 8, 2020

Lead plaintiff deadline: November 30, 2020

Visit: www.hbsslaw.com/investor-fraud/TCMD

Contact an attorney now: TCMD@hbsslaw.com

844-916-0895

Hagens Bermans Tactile Securities Litigation:

Throughout the classroom, defendants allegedly misrepresented and withheld the following: (1) While Tactile publicly announced a $ 4 plus billion or $ 5 billion market opportunity, the truth is that Tactile’s overall addressable market for medical devices was much smaller; (2) To induce sales growth and stock gains, Tactile engages in illegal sales and marketing activities; and (3) Tactile’s revenues were, in part, the product of unlawful conduct and therefore unsustainable.

The truth began to emerge on March 20, 2019 when an amended Qui Tam complaint against Tactile was lifted, which contained detailed allegations of illegal sales practices on the part of Tactile and prompted the company to file fraudulent claims with Medicare and the VA.

Then, on February 21, 2020, the court issued an order in the Qui Tam action denying Tactile’s motion for full dismissal.

Finally, on June 8, 2020, research firm OSS Research published a damning report on the company accusing Tactile of using a “daisy-chaining” kickback scheme resulting in widespread overprescription and rapid market share gains at the expense of patients has led. Insurers and the public. ”

Overall, this information resulted in tactile securities falling sharply and destroying significant shareholder value.

If you are a TCMD investor, click here to discuss your statutory rights with Hagens Berman. You can get a copy of the complaint here.

“We’re focusing on investor losses and proving that Tactile has deceived investors by conducting illegal marketing efforts to encourage revenue growth,” said Reed Kathrein, the Hagens Berman partner who led the investigation.

Whistleblowers: Individuals with nonpublic information about Tactile should review their options to help with the investigation or use the SEC whistleblower program. Under the new program, whistleblowers who provide original information can receive rewards of up to 30 percent for each successful SEC recovery. For more information, call Reed Kathrein at 844-916-0895 or send an email to TCMD@hbsslaw.com.

# # #

About Hagens Berman

Hagens Berman is a national law firm with nine offices in eight cities across the country and eighty attorneys. The firm represents investors, whistleblowers, employees and consumers in complex legal disputes. More information about the company and its achievements can be found at hbsslaw.com. For the latest news, visit our newsroom or follow us on Twitter @classactionlaw.

The source version of this press release can be found at https://www.newsfilecorp.com/release/69136

310

LEAVE A REPLY

Please enter your comment!
Please enter your name here